Lenvatinib combined with PD-1 inhibitor for advanced hepatocarcinoma: A meta-analysis

JIANG Wei, BI Xiao-man, ZHENG Shao-jiang

China Tropical Medicine ›› 2022, Vol. 22 ›› Issue (3) : 206-211.

PDF(2283 KB)
PDF(2283 KB)
China Tropical Medicine ›› 2022, Vol. 22 ›› Issue (3) : 206-211. DOI: 10.13604/j.cnki.46-1064/r.2022.03.03
Articles

Lenvatinib combined with PD-1 inhibitor for advanced hepatocarcinoma: A meta-analysis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 22(3): 206-211 https://doi.org/10.13604/j.cnki.46-1064/r.2022.03.03

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2283 KB)

Accesses

Citation

Detail

Sections
Recommended

/